{"database": "openregs", "table": "documents", "is_view": false, "human_description_en": "where agency_id = \"FDA\", document_type = \"Notice\" and posted_year = 2011 sorted by posted_date descending", "rows": [["FDA-2008-D-0659-0034", "FDA", "FDA-2008-D-0659", "Guidance for Industry Current Good Tissue Practice and Additional Requirements for Manufacturers of Human Cells, Tissues, and Cellular and Tissue-Based Products; Availability", "Notice", "Notice of Availability", "2011-12-30T05:00:00Z", 2011, 12, "2011-12-30T05:00:00Z", null, "2024-11-11T21:35:46Z", "2011-33572", 1, 0, "0900006480f8b716"], ["FDA-2011-N-0002-0153", "FDA", "FDA-2011-N-0002", "Oncologic Drugs Advisory Committee; Notice of Meeting", "Notice", "Meeting", "2011-12-30T05:00:00Z", 2011, 12, "2011-12-30T05:00:00Z", null, "2011-12-30T14:13:50Z", "2011-33552", 0, 0, "0900006480f8b71a"], ["FDA-2011-N-0002-0155", "FDA", "FDA-2011-N-0002", "Oncologic Drugs Advisory Committee; Notice of Meeting", "Notice", "Meeting", "2011-12-30T05:00:00Z", 2011, 12, "2011-12-30T05:00:00Z", null, "2011-12-30T14:38:03Z", "2011-33548", 0, 0, "0900006480f8b7c4"], ["FDA-2011-D-0868-0001", "FDA", "FDA-2011-D-0868", "Draft Guidance for Industry Responding to Unsolicited Requests for Off-Label Information About Prescription Drugs and Medical Devices; Availability", "Notice", "Notice of Availability", "2011-12-30T05:00:00Z", 2011, 12, "2011-12-30T05:00:00Z", "2012-03-30T03:59:59Z", "2020-04-29T00:35:05Z", "2011-33550", 0, 0, "0900006480f8b728"], ["FDA-2011-N-0827-0001", "FDA", "FDA-2011-N-0827", "Agency Information Collection Activities; Proposals, Submissions, and Approvals: Labeling Requirements for Blood and Blood Components, Including Source Plasma; Revisions", "Notice", "General Notice", "2011-12-30T05:00:00Z", 2011, 12, "2011-12-30T05:00:00Z", "2012-02-29T04:59:59Z", "2011-12-30T14:28:59Z", "2011-33555", 0, 0, "0900006480f8b750"], ["FDA-2009-N-0247-0300", "FDA", "FDA-2009-N-0247", "Report on Good Guidance Practices Improving Efficiency and Transparency; Availability", "Notice", "Availability of Document", "2011-12-30T05:00:00Z", 2011, 12, "2011-12-30T05:00:00Z", "2012-02-29T04:59:59Z", "2011-12-30T14:36:05Z", "2011-33573", 0, 0, "0900006480f8b7c2"], ["FDA-2011-N-0002-0154", "FDA", "FDA-2011-N-0002", "Cardiovascular and Renal Drugs Advisory Committee; Notice of Meeting", "Notice", "Meeting", "2011-12-30T05:00:00Z", 2011, 12, "2011-12-30T05:00:00Z", null, "2011-12-30T14:26:10Z", "2011-33561", 0, 0, "0900006480f8b74c"], ["FDA-2008-P-0555-0004", "FDA", "FDA-2008-P-0555", "Determinations that Drugs Were Not Withdrawn from Sale for Reasons of Safety or Effectiveness: HYCODAN", "Notice", "General Notice", "2011-12-30T05:00:00Z", 2011, 12, "2011-12-30T05:00:00Z", null, "2011-12-30T13:50:53Z", "2011-33549", 0, 0, "0900006480f8b709"], ["FDA-2011-D-0872-0001", "FDA", "FDA-2011-D-0872", "Draft Guidance for Industry on Use of Histology in Biomarker Qualification Studies; Availabilty", "Notice", "Notice of Availability", "2011-12-30T05:00:00Z", 2011, 12, "2011-12-30T05:00:00Z", "2012-03-30T03:59:59Z", "2013-11-23T02:02:25Z", "2011-33553", 0, 0, "0900006480f8b6cb"], ["FDA-2011-N-0619-0002", "FDA", "FDA-2011-N-0619", "Agency Information Collection Activities; Proposals, Submissions, and Approvals: Medical Devices; Humanitarian Use Devices", "Notice", "General Notice", "2011-12-30T05:00:00Z", 2011, 12, "2011-12-30T05:00:00Z", "2012-01-31T04:59:59Z", "2011-12-30T13:41:14Z", "2011-33551", 0, 0, "0900006480f8b6e5"], ["FDA-2011-N-0345-0003", "FDA", "FDA-2011-N-0345", "Agency Information Collection Activities; Proposals, Submissions, and Approvals: Experimental Study on Consumer Responses to Nutrition Facts Labels, etc.", "Notice", "General Notice", "2011-12-29T05:00:00Z", 2011, 12, "2011-12-29T05:00:00Z", "2012-01-31T04:59:59Z", "2014-06-14T01:03:15Z", "2011-33303", 0, 0, "0900006480f8abb7"], ["FDA-2011-D-0652-0001", "FDA", "FDA-2011-D-0652", "Draft Guidances for Industry and Staff; Availability: 510(k) Program, Evaluating Substantial Equivalence in Premarket Notifications; Availability", "Notice", "Notice of Availability", "2011-12-28T05:00:00Z", 2011, 12, "2011-12-28T05:00:00Z", "2012-04-27T03:59:59Z", "2012-05-25T02:00:27Z", "2011-33232", 0, 0, "0900006480f8a26b"], ["FDA-2011-N-0912-0001", "FDA", "FDA-2011-N-0912", "Communications and Activities: Off-Label Uses of Marketed Products and Use of Products Not Yet Legally Marketed", "Notice", "General Notice", "2011-12-28T05:00:00Z", 2011, 12, "2011-12-28T05:00:00Z", "2012-03-28T03:59:59Z", "2012-05-04T12:01:27Z", "2011-33188", 0, 0, "0900006480f8a26a"], ["FDA-2011-N-0002-0152", "FDA", "FDA-2011-N-0002", "Meetings: Cellular, Tissue, and Gene Therapies Advisory Committee", "Notice", "Meeting", "2011-12-28T05:00:00Z", 2011, 12, "2011-12-28T05:00:00Z", null, "2011-12-28T20:10:31Z", "2011-33220", 0, 0, "0900006480f8a239"], ["FDA-2011-D-0893-0001", "FDA", "FDA-2011-D-0893", "Draft Guidances for Industry and Staff; Availability: Center for Devices and Radiological Health Appeals Processes", "Notice", "Notice of Availability", "2011-12-28T05:00:00Z", 2011, 12, "2011-12-28T05:00:00Z", "2012-04-27T03:59:59Z", "2014-01-13T17:39:02Z", "2011-33230", 0, 0, "0900006480f8a2c3"], ["FDA-2010-D-0313-0017", "FDA", "FDA-2010-D-0313", "Guidance for Industry: Prevention of Salmonella Enteritidis in Shell Eggs During Production, Storage, and Transportation; Availability", "Notice", "Notice of Availability", "2011-12-28T05:00:00Z", 2011, 12, "2011-12-28T05:00:00Z", null, "2024-11-07T01:39:58Z", "2011-33292", 1, 0, "0900006480f8a23c"], ["FDA-2011-N-0002-0151", "FDA", "FDA-2011-N-0002", "Requests for Nominations: Voting Members on Public Advisory Panels or Committees", "Notice", "General Notice", "2011-12-27T05:00:00Z", 2011, 12, "2011-12-27T05:00:00Z", null, "2011-12-27T16:38:57Z", "2011-33060", 0, 0, "0900006480f898b3"], ["FDA-2011-N-0915-0001", "FDA", "FDA-2011-N-0915", "Agency Information Collection Activities; Proposals, Submissions, and Approvals: Guidance for Industry on Postmarketing Adverse Event Reporting for Nonprescription Human Drug Products, etc.", "Notice", "General Notice", "2011-12-27T05:00:00Z", 2011, 12, "2011-12-27T05:00:00Z", "2012-02-28T04:59:59Z", "2011-12-27T16:45:58Z", "2011-33140", 0, 0, "0900006480f89156"], ["FDA-2011-D-0787-0003", "FDA", "FDA-2011-D-0787", "Draft Guidance for Industry and Staff; Availability: Investigational Device Exemptions for Early Feasibility Medical Device Clinical Studies, Including Certain First in Human Studies", "Notice", "Notice of Extension", "2011-12-27T05:00:00Z", 2011, 12, "2011-12-27T05:00:00Z", "2012-03-10T04:59:59Z", "2011-12-27T16:55:21Z", "2011-33142", 0, 0, "0900006480f89d41"], ["FDA-2011-D-0790-0004", "FDA", "FDA-2011-D-0790", "Draft Guidance for Industry, Clinical Investigators, Institutional Review Boards, and Staff; Availability: Decisions for Investigational Device Exemption Clinical Investigations", "Notice", "Notice of Extension", "2011-12-27T05:00:00Z", 2011, 12, "2011-12-27T05:00:00Z", "2012-03-10T04:59:59Z", "2011-12-27T17:03:18Z", "2011-33141", 0, 0, "0900006480f89877"], ["FDA-2011-N-0002-0150", "FDA", "FDA-2011-N-0002", "Requests for Nominations: Food Advisory Committee Voting Members", "Notice", "General Notice", "2011-12-27T05:00:00Z", 2011, 12, "2011-12-27T05:00:00Z", null, "2011-12-27T16:32:38Z", "2011-33108", 0, 0, "0900006480f89874"], ["FDA-2011-N-0002-0149", "FDA", "FDA-2011-N-0002", "Endocrinologic and Metabolic Drugs Advisory Committee Meeting", "Notice", "Meeting", "2011-12-27T05:00:00Z", 2011, 12, "2011-12-27T05:00:00Z", null, "2011-12-27T16:27:31Z", "2011-33059", 0, 0, "0900006480f89822"], ["FDA-1977-N-0014-1438", "FDA", "FDA-1977-N-0014", "Withdrawal of Notices of Opportunity for a Hearing: Penicillin and Tetracycline Used in Animal Feed", "Notice", "Withdrawal", "2011-12-22T05:00:00Z", 2011, 12, "2011-12-22T05:00:00Z", null, "2019-04-09T18:17:07Z", "2011-32775", 0, 0, "0900006480f87dc5"], ["FDA-2011-N-0508-0002", "FDA", "FDA-2011-N-0508", "Agency Information Collection Activities; Proposals, Submissions, and Approvals: Blood Establishment Registration and Product Listing", "Notice", "General Notice", "2011-12-22T05:00:00Z", 2011, 12, null, null, "2011-12-22T17:02:14Z", "2011-32777", 0, 0, "0900006480f87cba"], ["FDA-1977-N-0019-0067", "FDA", "FDA-1977-N-0019", "Withdrawal of Notices of Opportunity for a Hearing; Penicillin and Tetracycline Used in Animal Feed", "Notice", "Withdrawal", "2011-12-22T05:00:00Z", 2011, 12, "2011-12-22T05:00:00Z", null, "2019-04-25T18:21:26Z", "2011-32775", 0, 0, "0900006480f87c5a"], ["FDA-1977-N-0022-0146", "FDA", "FDA-1977-N-0022", "Withdrawal of Notices of Opportunity for a Hearing: Penicillin and Tetracycline Used in Animal Feed", "Notice", "Withdrawal", "2011-12-22T05:00:00Z", 2011, 12, null, null, "2011-12-22T16:45:03Z", "2011-32775", 0, 0, "0900006480f87ea8"], ["FDA-2011-N-0511-0002", "FDA", "FDA-2011-N-0511", "Agency Information Collection Activities; Proposals, Submissions, andApprovals: Current Good Manufacturing Practices and Related Regulations for Blood and Blood Components, etc.", "Notice", "General Notice", "2011-12-22T05:00:00Z", 2011, 12, null, null, "2011-12-22T14:02:15Z", "2011-32778", 0, 0, "0900006480f87c31"], ["FDA-2011-N-0908-0001", "FDA", "FDA-2011-N-0908", "Agency Information Collection Activities; Proposals, Submissions, and Approvals: Establishment and Operation of Clinical Trial Data Monitoring Committees", "Notice", "General Notice", "2011-12-22T05:00:00Z", 2011, 12, "2011-12-22T05:00:00Z", "2012-02-22T04:59:59Z", "2011-12-22T17:04:41Z", "2011-32776", 0, 0, "0900006480f87d15"], ["FDA-1977-N-0224-0138", "FDA", "FDA-1977-N-0224", "Withdrawal of Notices of Opportunity for a Hearing: Penicillin and Tetracycline Used in Animal Feed", "Notice", "Withdrawal", "2011-12-22T05:00:00Z", 2011, 12, "2011-12-22T05:00:00Z", null, "2019-04-29T15:42:47Z", "2011-32775", 0, 0, "0900006480f87ed5"], ["FDA-2011-N-0411-0003", "FDA", "FDA-2011-N-0411", "Withdrawal of Approval of 70 New Drug Applications and 97 Abbreviated New Drug Applications: Bristol-Myers Squibb Co., et al.; Correction", "Notice", "Correction", "2011-12-22T05:00:00Z", 2011, 12, null, null, "2011-12-22T17:07:37Z", "2011-32822", 0, 0, "0900006480f87d1a"], ["FDA-2011-N-0902-0001", "FDA", "FDA-2011-N-0902", "Agency Information Collection Activities; Proposals, Submissions, and Approvals: Prescription Drug Product Labeling; Medication Guide Requirements", "Notice", "60 Day Proposed Information Collection", "2011-12-21T05:00:00Z", 2011, 12, "2011-12-21T05:00:00Z", "2012-02-22T04:59:59Z", "2011-12-21T21:40:13Z", "2011-32548", 0, 0, "0900006480f87038"], ["FDA-2011-N-0656-0002", "FDA", "FDA-2011-N-0656", "Animal Drug User Fee Act; Reopening of Comment Period", "Notice", "Notice of Extension", "2011-12-21T05:00:00Z", 2011, 12, "2011-12-21T05:00:00Z", "2013-01-16T04:59:59Z", "2013-01-16T03:07:49Z", "2011-32567", 0, 0, "0900006480f87129"], ["FDA-2011-N-0842-0001", "FDA", "FDA-2011-N-0842", "Gluten in Drug Products", "Notice", "General Notice", "2011-12-21T05:00:00Z", 2011, 12, "2011-12-21T05:00:00Z", "2012-03-21T03:59:59Z", "2011-12-21T21:31:22Z", "2011-32551", 0, 0, "0900006480f87037"], ["FDA-2011-N-0655-0003", "FDA", "FDA-2011-N-0655", "Animal Generic Drug User Fee Act; Reopening of Comment Period", "Notice", "Notice of Extension", "2011-12-21T05:00:00Z", 2011, 12, "2011-12-21T05:00:00Z", "2013-01-16T04:59:59Z", "2012-12-11T03:01:51Z", "2011-32565", 0, 0, "0900006480f8703b"], ["FDA-2010-N-0381-0051", "FDA", "FDA-2010-N-0381", "Meetings: Generic Drug User Fee; Correction", "Notice", "General Notice", "2011-12-21T05:00:00Z", 2011, 12, "2011-12-21T05:00:00Z", null, "2011-12-21T22:13:01Z", "2011-32562", 0, 0, "0900006480f870d0"], ["FDA-2011-N-0885-0001", "FDA", "FDA-2011-N-0885", "Rare Disease Patient Advocacy Day Meeting", "Notice", "Meeting", "2011-12-20T05:00:00Z", 2011, 12, "2011-12-20T05:00:00Z", null, "2011-12-20T14:44:21Z", "2011-32436", 0, 0, "0900006480f8650c"], ["FDA-2011-N-0849-0001", "FDA", "FDA-2011-N-0849", "Establishing Timeframes for Implementation of Product Safety Labeling Changes", "Notice", "General Notice", "2011-12-20T05:00:00Z", 2011, 12, "2011-12-20T05:00:00Z", "2012-02-22T04:59:59Z", "2011-12-20T15:14:43Z", "2011-32438", 0, 0, "0900006480f8652b"], ["FDA-2011-N-0002-0148", "FDA", "FDA-2011-N-0002", "Clinical Trial Requirements, Regulations, Compliance, and Good Clinical Practice; Public Workshop", "Notice", "Meeting", "2011-12-20T05:00:00Z", 2011, 12, "2011-12-20T05:00:00Z", null, "2011-12-20T16:34:16Z", "2011-32435", 0, 0, "0900006480f864d2"], ["FDA-2011-D-0476-0009", "FDA", "FDA-2011-D-0476", "Guidance for Industry and Staff; Availability: Enforcement Policy for Premarket Notification Requirements for Certain In Vitro Diagnostic and Radiology Devices", "Notice", "Notice of Availability", "2011-12-20T05:00:00Z", 2011, 12, "2011-12-20T05:00:00Z", null, "2012-03-24T19:36:40Z", "2011-32437", 0, 0, "0900006480f86544"], ["FDA-2011-N-0002-0147", "FDA", "FDA-2011-N-0002", "Advisory Committees Meeting", "Notice", "General Notice", "2011-12-20T05:00:00Z", 2011, 12, "2011-12-20T05:00:00Z", null, "2011-12-20T14:30:40Z", "2011-32469", 0, 0, "0900006480f86432"], ["FDA-2011-F-0765-0001", "FDA", "FDA-2011-F-0765", "Filings of Food Additive Petitions: Nexira", "Notice", "Notice of Filing", "2011-12-20T05:00:00Z", 2011, 12, "2011-12-20T05:00:00Z", null, "2011-12-20T15:06:51Z", "2011-32542", 0, 0, "0900006480f864a8"], ["FDA-2011-N-0883-0001", "FDA", "FDA-2011-N-0883", "Agency Information Collection Activities; Proposals, Submissions, and Approvals: Requirements on Content and Format of Labeling for Human Prescription Drug and Biological Products", "Notice", "General Notice", "2011-12-19T05:00:00Z", 2011, 12, "2011-12-19T05:00:00Z", "2012-02-18T04:59:59Z", "2011-12-19T14:24:12Z", "2011-32397", 0, 0, "0900006480f858fa"], ["FDA-2011-D-0817-0001", "FDA", "FDA-2011-D-0817", "Draft Guidance for Industry and Food and Drug Administration Staff, Availability: Evaluation of Sex Differences in Medical Device Clinical Studies", "Notice", "Notice of Availability", "2011-12-19T05:00:00Z", 2011, 12, "2011-12-19T05:00:00Z", "2012-03-20T03:59:59Z", "2011-12-19T15:02:25Z", "2011-32368", 0, 0, "0900006480f859d0"], ["FDA-2011-N-0230-0011", "FDA", "FDA-2011-N-0230", "Agency Information Collection Activities; Proposals, Submissions, and Approvals: Examination of Online Direct-to-Consumer Prescription Drug Promotion", "Notice", "General Notice", "2011-12-19T05:00:00Z", 2011, 12, "2011-12-19T05:00:00Z", "2012-01-19T04:59:59Z", "2012-03-24T19:36:35Z", "2011-32275", 0, 0, "0900006480f858fb"], ["FDA-2011-P-0578-0003", "FDA", "FDA-2011-P-0578", "Determinations: BRETYLIUM TOSYLATE Injection, 50 Milligrams/Milliliter Not Withdrawn From Sale for Reasons of Safety or Effectiveness", "Notice", "General Notice", "2011-12-19T05:00:00Z", 2011, 12, "2011-12-19T05:00:00Z", null, "2011-12-19T14:30:56Z", "2011-32367", 0, 0, "0900006480f859b0"], ["FDA-2011-N-0002-0145", "FDA", "FDA-2011-N-0002", "Anesthetic and Analgesic Drug Products Advisory Committee Meeting", "Notice", "Meeting", "2011-12-16T05:00:00Z", 2011, 12, "2011-12-16T05:00:00Z", null, "2011-12-16T18:16:47Z", "2011-32206", 0, 0, "0900006480f84680"], ["FDA-2011-N-0002-0146", "FDA", "FDA-2011-N-0002", "Pediatric Advisory Committee Meeting", "Notice", "Meeting", "2011-12-16T05:00:00Z", 2011, 12, "2011-12-16T05:00:00Z", null, "2011-12-16T18:22:13Z", "2011-32205", 0, 0, "0900006480f8475c"], ["FDA-2011-N-0867-0001", "FDA", "FDA-2011-N-0867", "Agency Information Collection Activities; Proposals, Submissions, and Approvals: Experimental Study on PublicDisplay of Lists of Harmful and Potentially Harmful Tobacco Constituents", "Notice", "General Notice", "2011-12-14T05:00:00Z", 2011, 12, "2011-12-14T05:00:00Z", "2012-02-14T04:59:59Z", "2011-12-14T14:27:48Z", "2011-32026", 0, 0, "0900006480f82439"], ["FDA-2011-N-0535-0002", "FDA", "FDA-2011-N-0535", "Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Guidance for \r\nIndustry: Notification of a Health Claim or Nutrient Content Claim Based on an Authoritative Statement of a Scientific Body", "Notice", "General Notice", "2011-12-14T05:00:00Z", 2011, 12, null, null, "2014-11-14T17:18:58Z", "2011-32025", 0, 0, "0900006480f823fd"], ["FDA-2011-N-0813-0001", "FDA", "FDA-2011-N-0813", "Quantitative Summary of the Benefits and Risks of Prescription Drugs - A Literature Review; Availability", "Notice", "General Notice", "2011-12-13T05:00:00Z", 2011, 12, "2011-12-13T05:00:00Z", "2012-02-14T04:59:59Z", "2011-12-13T15:03:29Z", "2011-31931", 0, 0, "0900006480f8128e"], ["FDA-2011-D-0847-0001", "FDA", "FDA-2011-D-0847", "Draft Guidance for Industry and Staff; Availability Humanitarian Use Device Designations", "Notice", "Notice of Availability", "2011-12-13T05:00:00Z", 2011, 12, "2011-12-13T05:00:00Z", null, "2011-12-13T14:32:48Z", "2011-31867", 0, 0, "0900006480f812ab"], ["FDA-2011-N-0457-0003", "FDA", "FDA-2011-N-0457", "Agency Information Collection Activities; Proposals, Submissions, and Approvals: Experimental Study of Comparative Direct-to-Consumer Advertising", "Notice", "General Notice", "2011-12-09T05:00:00Z", 2011, 12, null, null, "2011-12-09T15:51:40Z", "2011-31609", 0, 0, "0900006480f7ed8a"], ["FDA-2011-N-0769-0001", "FDA", "FDA-2011-N-0769", "Notice of Listing of Members of the Food and Drug Administration\u2019s Senior Executive Service Performance Review Board Members", "Notice", "General Notice", "2011-12-09T05:00:00Z", 2011, 12, "2011-12-09T05:00:00Z", null, "2011-12-09T15:56:13Z", "2011-31579", 0, 0, "0900006480f7edc4"], ["FDA-2010-N-0381-0048", "FDA", "FDA-2010-N-0381", "Generic Drug User Fee; Public Meeting", "Notice", "Meeting", "2011-12-08T05:00:00Z", 2011, 12, "2011-12-08T05:00:00Z", "2012-01-07T04:59:59Z", "2011-12-08T14:13:25Z", "2011-31630", 0, 0, "0900006480f7df83"], ["FDA-2011-N-0326-0024", "FDA", "FDA-2011-N-0326", "Recommendations for User Fee Programs: Biosimilar and Interchangeable Biological Product Applications for Fiscal Years 2013 Through 2017; Meeting", "Notice", "Public Meetings", "2011-12-07T05:00:00Z", 2011, 12, "2011-12-07T05:00:00Z", "2012-01-07T04:59:59Z", "2012-03-24T19:31:36Z", "2011-31499", 0, 0, "0900006480f7d578"], ["FDA-2011-N-0608-0009", "FDA", "FDA-2011-N-0608", "Agency Information Collection Activities; Proposals, Submissions, and Approvals: MedWatch; Medical Products Reporting Program", "Notice", "General Notice", "2011-12-07T05:00:00Z", 2011, 12, "2011-12-07T05:00:00Z", null, "2012-03-24T19:36:39Z", "2011-31341", 0, 0, "0900006480f7d55c"], ["FDA-2011-N-0858-0001", "FDA", "FDA-2011-N-0858", "Agency Information Collection Activities; Proposals, Submissions, and Approvals: Experimental Study on Comparing Data Obtained From Landline Telephone and Cell Phone Surveys", "Notice", "General Notice", "2011-12-07T05:00:00Z", 2011, 12, "2011-12-07T05:00:00Z", "2012-02-07T04:59:59Z", "2011-12-07T21:23:02Z", "2011-31389", 0, 0, "0900006480f7d579"], ["FDA-2011-N-0824-0001", "FDA", "FDA-2011-N-0824", "Regulatory Site Visit Training Program", "Notice", "General Notice", "2011-12-06T05:00:00Z", 2011, 12, "2011-12-06T05:00:00Z", "2011-01-06T04:59:59Z", "2011-12-13T16:56:03Z", "2011-31152", 0, 0, "0900006480f7c5aa"], ["FDA-2011-D-0464-0034", "FDA", "FDA-2011-D-0464", "Draft Guidance for Industry and Staff; Availability: Content of Investigational Device Exemption and Premarket Approval Applications for Artificial Pancreas Device Systems", "Notice", "Notice of Availability", "2011-12-06T05:00:00Z", 2011, 12, "2011-12-06T05:00:00Z", null, "2011-12-06T14:16:35Z", "2011-31214", 0, 0, "0900006480f7c57a"], ["FDA-2010-P-0176-0086", "FDA", "FDA-2010-P-0176", "SEDASYS Computer-Assisted Personalized Sedation System: Ethicon Endo-Surgery, Inc. Petition for Review of Denial of Premarket Approval; Meeting Cancellation", "Notice", "General Notice", "2011-12-05T05:00:00Z", 2011, 12, "2011-12-05T05:00:00Z", null, "2011-12-05T14:42:36Z", "2011-31105", 0, 0, "0900006480f7b64c"], ["FDA-2011-N-0826-0001", "FDA", "FDA-2011-N-0826", "Determinations That Drug Products Were Not Withdrawn From Sale for Reasons of Safety or Effectiveness: DEMULEN 1/50-28 (Ethinyl Estradiol; Ethynodiol Diacetate) Tablet and Four Other Drug Products", "Notice", "General Notice", "2011-12-05T05:00:00Z", 2011, 12, "2011-12-05T05:00:00Z", null, "2011-12-05T14:36:14Z", "2011-31146", 0, 0, "0900006480f7b5b9"], ["FDA-2011-D-0800-0001", "FDA", "FDA-2011-D-0800", "Draft Guidance for Industry; Availability: Regulatory Classification of Pharmaceutical Co-Crystals", "Notice", "Notice of Availability", "2011-12-02T05:00:00Z", 2011, 12, "2011-12-02T05:00:00Z", "2012-03-02T04:59:59Z", "2011-12-02T14:13:26Z", "2011-31022", 0, 0, "0900006480f7a304"], ["FDA-2011-N-0005-0003", "FDA", "FDA-2011-N-0005", "Memorandum of Understanding", "Notice", "General Notice", "2011-12-01T05:00:00Z", 2011, 12, "2011-12-01T05:00:00Z", null, "2011-12-02T13:26:22Z", "2011-30911", 0, 0, "0900006480f792d5"], ["FDA-2011-N-0327-0002", "FDA", "FDA-2011-N-0327", "Agency Information Collection Activities; Proposals, Submissions, and Approvals: Generic Clearance for Collection of Qualitative Feedback on FDA Service Delivery", "Notice", "Notice of Approval", "2011-12-01T05:00:00Z", 2011, 12, "2011-12-01T05:00:00Z", null, "2012-03-24T19:30:21Z", "2011-30877", 0, 0, "0900006480f79309"], ["FDA-2011-N-0400-0038", "FDA", "FDA-2011-N-0400", "Approaches to Reducing Sodium Consumption; Establishment of Dockets: Request for Comments, Data, and Information; Extension of Comment Period", "Notice", "Notice of Extension", "2011-11-30T05:00:00Z", 2011, 11, "2011-11-30T05:00:00Z", "2012-01-28T04:59:59Z", "2015-01-28T03:03:16Z", "2011-30865", 0, 0, "0900006480f76cbd"], ["FDA-1986-P-0011-0002", "FDA", "FDA-1986-P-0011", "Petitions Requesting Exclusivety for Certain Chlorhexidine Gluconate Products", "Notice", "Notice of Filing", "2011-11-30T05:00:00Z", 2011, 11, "2011-11-30T05:00:00Z", null, "2011-11-30T17:28:21Z", null, 0, 0, "090000648050d94c"], ["FDA-2009-N-0264-0002", "FDA", "FDA-2009-N-0264", "Authorization of Emergency Use; Availability: Doxycycline Hyclate Tablet Emergency Kits for Eligible United States Postal Service Participants and Their Household Members", "Notice", "General Notice", "2011-11-28T05:00:00Z", 2011, 11, "2011-11-28T05:00:00Z", null, "2012-03-24T19:36:39Z", "2011-30450", 0, 0, "0900006480f744ac"], ["FDA-2011-N-0828-0001", "FDA", "FDA-2011-N-0828", "Withdrawals of Approval of New Drug Applications: MYLOTARG, Wyeth Pharmaceuticals, Inc.", "Notice", "Withdrawal", "2011-11-28T05:00:00Z", 2011, 11, "2011-11-28T05:00:00Z", null, "2011-11-28T15:27:07Z", "2011-30473", 0, 0, "0900006480f74426"], ["FDA-2009-D-0386-0009", "FDA", "FDA-2009-D-0386", "Guidance for Industry and Staff; Availability: Establishing Performance Characteristics of In Vitro Diagnostic Devices for the Detection, etc., of Human Papillomaviruses", "Notice", "Notice of Availability", "2011-11-28T05:00:00Z", 2011, 11, "2011-11-28T05:00:00Z", null, "2015-07-29T16:44:35Z", "2011-30552", 0, 0, "0900006480f743be"], ["FDA-2011-N-0002-0143", "FDA", "FDA-2011-N-0002", "Nominations for Voting Members on Public Advisory Committee, Science Board", "Notice", "General Notice", "2011-11-28T05:00:00Z", 2011, 11, "2011-11-28T05:00:00Z", null, "2011-11-28T14:19:43Z", "2011-30415", 0, 0, "0900006480f743ed"], ["FDA-2011-D-0799-0001", "FDA", "FDA-2011-D-0799", "Draft Guidance for Industry: Use of Nucleic Acid Tests on Pooled and\nIndividual Samples From Donors of Whole Blood and Blood Components,\nIncluding Source Plasma, to Reduce the Risk of Transmission of Hepatitis\nB Virus", "Notice", "Notice of Availability", "2011-11-28T05:00:00Z", 2011, 11, "2011-11-28T05:00:00Z", "2012-01-28T04:59:59Z", "2015-04-03T22:40:47Z", "2011-30449", 0, 0, "0900006480f74467"], ["FDA-2011-N-0002-0144", "FDA", "FDA-2011-N-0002", "Science Board to the Food and Drug Administration Meeting", "Notice", "Meeting", "2011-11-28T05:00:00Z", 2011, 11, "2011-11-28T05:00:00Z", null, "2011-11-28T14:25:12Z", "2011-30416", 0, 0, "0900006480f743bc"], ["FDA-2005-D-0086-0005", "FDA", "FDA-2005-D-0086", "Guidance for Industry; Availability: Nonclinical Evaluation of Late Radiation Toxicity of Therapeutic Radiopharmaceuticals", "Notice", "Notice of Availability", "2011-11-28T05:00:00Z", 2011, 11, "2011-11-28T05:00:00Z", null, "2011-11-28T15:40:22Z", "2011-30474", 0, 0, "0900006480f743db"], ["FDA-2011-P-0488-0003", "FDA", "FDA-2011-P-0488", "Determination That Products Were Not Withdrawn From Sale for Reasons of Safety or Effectiveness: TAXOTERE (Docetaxel) Injection, 40 Milligrams/Milliliter", "Notice", "General Notice", "2011-11-28T05:00:00Z", 2011, 11, "2011-11-28T05:00:00Z", null, "2011-11-28T14:59:00Z", "2011-30472", 0, 0, "0900006480f74452"], ["FDA-2011-N-0231-0004", "FDA", "FDA-2011-N-0231", "Agency Information Collection Activities; Proposals, Submissions, and Approvals", "Notice", "Notice of Approval", "2011-11-25T05:00:00Z", 2011, 11, "2011-11-25T05:00:00Z", null, "2011-11-25T14:16:51Z", "2011-30326", 0, 0, "0900006480f73634"], ["FDA-2011-N-0841-0001", "FDA", "FDA-2011-N-0841", "Agency Information Collection Activities; Proposals, Submissions, and Approvals: Food Safety Modernization Act; Economic Hardship Fee Reduction Guidance", "Notice", "General Notice", "2011-11-25T05:00:00Z", 2011, 11, "2011-11-25T05:00:00Z", "2011-12-16T04:59:59Z", "2011-11-25T14:12:21Z", "2011-30471", 0, 0, "0900006480f735ce"], ["FDA-2010-D-0350-0009", "FDA", "FDA-2010-D-0350", "Agency Information Collection Activities; Proposals, Submissions, and Approvals: Draft Guidance for Tobacco Retailers on Tobacco Retailer Training Programs", "Notice", "General Notice", "2011-11-25T05:00:00Z", 2011, 11, "2011-11-25T05:00:00Z", "2012-01-25T04:59:59Z", "2011-11-25T14:14:30Z", "2011-30327", 0, 0, "0900006480f73613"], ["FDA-2011-N-0002-0142", "FDA", "FDA-2011-N-0002", "Tobacco Products Scientific Advisory Committee; Notice of Meeting", "Notice", "Meeting", "2011-11-23T05:00:00Z", 2011, 11, "2011-11-23T05:00:00Z", null, "2011-11-23T14:55:39Z", "2011-30163", 0, 0, "0900006480f7209e"], ["FDA-2011-D-0784-0001", "FDA", "FDA-2011-D-0784", "Draft Guidance for Industry on Evaluating Effectiveness of Anticoccidial Drugs in Food-Producing Animals; Availability", "Notice", "Notice of Availability", "2011-11-23T05:00:00Z", 2011, 11, "2011-11-23T05:00:00Z", "2012-01-24T04:59:59Z", "2011-11-23T14:58:01Z", "2011-30149", 0, 0, "0900006480f720d9"], ["FDA-2011-N-0780-0001", "FDA", "FDA-2011-N-0780", "Bridging Idea Development Evaluation Assessment and Long-Term Initiative and Total Product Life Cycle, etc.; Correction", "Notice", "Correction", "2011-11-23T05:00:00Z", 2011, 11, "2011-11-23T05:00:00Z", null, "2011-11-23T15:03:50Z", "2011-30145", 0, 0, "0900006480f72512"], ["FDA-2011-N-0439-0003", "FDA", "FDA-2011-N-0439", "Agency Information Collection Activities; Proposals, Submissions, and Approvals: Recall Regulations", "Notice", "General Notice", "2011-11-23T05:00:00Z", 2011, 11, "2011-11-23T05:00:00Z", "2011-12-24T04:59:59Z", "2011-11-23T14:52:38Z", "2011-30146", 0, 0, "0900006480f7209a"], ["FDA-2010-P-0176-0084", "FDA", "FDA-2010-P-0176", "SEDASYS Computer-Assisted Personalized Sedation System; Ethicon Endo-Surgery, Inc.'s Petition for Review of FDA's Denial of Premarket Approval - Notice of Meeting", "Notice", "Meeting", "2011-11-21T05:00:00Z", 2011, 11, "2011-11-21T05:00:00Z", "2011-12-08T04:59:59Z", "2011-11-28T15:18:41Z", "2011-29888", 0, 0, "0900006480f70910"], ["FDA-2011-N-0557-0002", "FDA", "FDA-2011-N-0557", "Advancing Regulatory Science for Highly Multiplexed Microbiology/Medical Countermeasure Devices; Public Meeting; Reopening of Comment Period", "Notice", "Extension of Comment Period", "2011-11-21T05:00:00Z", 2011, 11, "2011-11-21T05:00:00Z", "2011-12-22T04:59:59Z", "2012-01-26T22:58:19Z", "2011-29937", 0, 0, "0900006480f70972"], ["FDA-2011-N-0002-0141", "FDA", "FDA-2011-N-0002", "Gastroenterology and Urology Devices Panel of Medical Devices Advisory Committee Meeting", "Notice", "Meeting", "2011-11-21T05:00:00Z", 2011, 11, "2011-11-21T05:00:00Z", null, "2011-11-21T14:52:52Z", "2011-29890", 0, 0, "0900006480f70957"], ["FDA-2011-N-0492-0002", "FDA", "FDA-2011-N-0492", "Agency Information Collection Activities; Proposals, Submissions, and Approvals: Class II Special Controls Guidance Document; Labeling for Natural Rubber Latex Condoms", "Notice", "30 Day Proposed Information Collection", "2011-11-18T05:00:00Z", 2011, 11, "2011-11-18T05:00:00Z", "2011-12-20T04:59:59Z", "2015-06-02T14:56:04Z", "2011-29839", 0, 0, "0900006480f6f613"], ["FDA-2011-N-0410-0008", "FDA", "FDA-2011-N-0410", "Agency Information Collection Activities; Proposals, Submissions, and Approvals: Premarket Notification for a New Dietary Ingredient", "Notice", "Notice of Approval", "2011-11-18T05:00:00Z", 2011, 11, "2011-11-18T05:00:00Z", null, "2011-11-18T14:26:19Z", "2011-29837", 0, 0, "0900006480f6f554"], ["FDA-2011-N-0099-0004", "FDA", "FDA-2011-N-0099", "Agency Information Collection Activities; Proposals, Submissions, and Approvals: Followup Study for Infant Feeding Practices Study II", "Notice", "Notice of Approval", "2011-11-18T05:00:00Z", 2011, 11, "2011-11-18T05:00:00Z", null, "2011-11-18T14:37:19Z", "2011-29836", 0, 0, "0900006480f6f604"], ["FDA-2011-D-0074-0024", "FDA", "FDA-2011-D-0074", "Guidance for Industry on Medication Guide Distribution Requirements and Inclusion of Medication Guides in Risk Evaluation and Mitigation Strategies; Availability", "Notice", "Notice of Data Availability", "2011-11-18T05:00:00Z", 2011, 11, "2011-11-18T05:00:00Z", null, "2019-10-21T13:22:31Z", "2011-29877", 0, 0, "0900006480f6f567"], ["FDA-2011-N-0802-0001", "FDA", "FDA-2011-N-0802", "Role of Naloxone in OpioidOverdose Fatality Prevention; Workshop; Request for Comments", "Notice", "Meeting", "2011-11-17T05:00:00Z", 2011, 11, "2011-11-17T05:00:00Z", "2012-06-13T03:59:59Z", "2012-06-14T02:02:30Z", "2011-29703", 0, 0, "0900006480f6e632"], ["FDA-2011-N-0805-0001", "FDA", "FDA-2011-N-0805", "Dermatologic and Ophthalmic Drugs Advisory Committee; Noyice of Meeting", "Notice", "Meeting", "2011-11-17T05:00:00Z", 2011, 11, "2011-11-17T05:00:00Z", "2012-03-06T04:59:59Z", "2012-02-23T19:46:45Z", "2011-29682", 0, 0, "0900006480f6e6ba"], ["FDA-2011-N-0599-0002", "FDA", "FDA-2011-N-0599", "Report of Scientific and Medical Literature and Information on Non-Standardized Allergenic Extracts, etc.: Center for Biologics Evaluation and Research; Extension of Comment Period", "Notice", "Notice of Extension", "2011-11-16T05:00:00Z", 2011, 11, "2011-11-16T05:00:00Z", "2012-04-26T03:59:59Z", "2015-03-04T03:16:11Z", "2011-29483", 0, 0, "0900006480f6d690"], ["FDA-2011-N-0402-0003", "FDA", "FDA-2011-N-0402", "Agency Information Collection Activities; Proposals, Submissions, and Approvals: State Petitions for Exemption for Preemption", "Notice", "Notice of Approval", "2011-11-16T05:00:00Z", 2011, 11, "2011-11-16T05:00:00Z", null, "2011-11-16T22:02:22Z", "2011-29511", 0, 0, "0900006480f6d62e"], ["FDA-2011-N-0793-0001", "FDA", "FDA-2011-N-0793", "Agency Information Collection Activities; Proposed Collection; Comment Request; Medical Device Recall Authority", "Notice", "60 Day Proposed Information Collection", "2011-11-16T05:00:00Z", 2011, 11, "2011-11-16T05:00:00Z", "2012-01-18T04:59:59Z", "2015-03-04T12:38:03Z", "2011-29512", 0, 0, "0900006480f6d712"], ["FDA-2011-D-0720-0003", "FDA", "FDA-2011-D-0720", "International Conference on Harmonisation: Electronic Transmission of Individual Case Safety Reports, etc., Correction", "Notice", "General Notice", "2011-11-16T05:00:00Z", 2011, 11, "2011-11-16T05:00:00Z", null, "2011-11-16T22:41:14Z", "2011-29485", 0, 0, "0900006480f6d72d"], ["FDA-2011-N-0425-0003", "FDA", "FDA-2011-N-0425", "Agency Information Collection Activities; Proposals, Submissions, and Approvals: Infant Formula Recall Regulations", "Notice", "Notice of Approval", "2011-11-16T05:00:00Z", 2011, 11, "2011-11-16T05:00:00Z", null, "2011-11-16T22:24:47Z", "2011-29479", 0, 0, "0900006480f6d6cf"], ["FDA-2011-N-0002-0140", "FDA", "FDA-2011-N-0002", "Meetings: Neurological Devices Panel of the Medical Devices Advisory Committee", "Notice", "Meeting", "2011-11-16T05:00:00Z", 2011, 11, "2011-11-16T05:00:00Z", null, "2011-11-16T22:17:24Z", "2011-29528", 0, 0, "0900006480f6d6f4"], ["FDA-2011-N-0377-0001", "FDA", "FDA-2011-N-0377", "Scott S. Reuben: Debarment Order", "Notice", "Notice of Final Rule", "2011-11-16T05:00:00Z", 2011, 11, "2011-11-16T05:00:00Z", null, "2024-11-07T22:42:40Z", "2011-29538", 1, 0, "0900006480f6d781"], ["FDA-2011-N-0555-0002", "FDA", "FDA-2011-N-0555", "Agency Information Collection Activities; Proposals, Submissions, and Approvals: Extralabel Drug Use in Animals", "Notice", "General Notice", "2011-11-16T05:00:00Z", 2011, 11, "2011-11-16T05:00:00Z", null, "2012-03-24T19:34:43Z", "2011-29477", 0, 0, "0900006480f6d747"], ["FDA-2011-N-0781-0001", "FDA", "FDA-2011-N-0781", "Agency Information Collection Activities; Proposals, Submissions, and Approvals: Record Retention Requirements for Soy Protein and Risk of Coronary Heart Disease Health Claim", "Notice", "60 Day Proposed Information Collection", "2011-11-16T05:00:00Z", 2011, 11, "2011-11-16T05:00:00Z", "2012-01-18T04:59:59Z", "2015-03-04T03:09:21Z", "2011-29478", 0, 0, "0900006480f6d636"], ["FDA-2011-P-0416-0003", "FDA", "FDA-2011-P-0416", "Determinations that Product was Not Withdrawn from Sale for Reasons of Safety or Effectiveness: TRAVATAN (Travoprost Ophthalmic Solution), 0.004 percent", "Notice", "General Notice", "2011-11-16T05:00:00Z", 2011, 11, "2011-11-16T05:00:00Z", null, "2011-11-16T22:11:54Z", "2011-29484", 0, 0, "0900006480f6d68f"]], "truncated": false, "filtered_table_rows_count": 837, "expanded_columns": [], "expandable_columns": [[{"column": "docket_id", "other_table": "dockets", "other_column": "id"}, "title"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "units": {}, "query": {"sql": "select id, agency_id, docket_id, title, document_type, subtype, posted_date, posted_year, posted_month, comment_start_date, comment_end_date, last_modified, fr_doc_num, open_for_comment, withdrawn, object_id from documents where \"agency_id\" = :p0 and \"document_type\" = :p1 and \"posted_year\" = :p2 order by posted_date desc limit 101", "params": {"p0": "FDA", "p1": "Notice", "p2": "2011"}}, "facet_results": {"agency_id": {"name": "agency_id", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?agency_id=FDA&document_type=Notice&posted_year=2011", "results": [{"value": "FDA", "label": "FDA", "count": 837, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?document_type=Notice&posted_year=2011", "selected": true}], "truncated": false}, "document_type": {"name": "document_type", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?agency_id=FDA&document_type=Notice&posted_year=2011", "results": [{"value": "Notice", "label": "Notice", "count": 837, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&posted_year=2011", "selected": true}], "truncated": false}, "posted_year": {"name": "posted_year", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?agency_id=FDA&document_type=Notice&posted_year=2011", "results": [{"value": 2011, "label": 2011, "count": 837, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&document_type=Notice", "selected": true}], "truncated": false}}, "suggested_facets": [{"name": "posted_month", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&document_type=Notice&posted_year=2011&_facet=posted_month"}, {"name": "open_for_comment", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&document_type=Notice&posted_year=2011&_facet=open_for_comment"}, {"name": "withdrawn", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&document_type=Notice&posted_year=2011&_facet=withdrawn"}, {"name": "posted_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&document_type=Notice&posted_year=2011&_facet_date=posted_date"}, {"name": "comment_start_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&document_type=Notice&posted_year=2011&_facet_date=comment_start_date"}, {"name": "comment_end_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&document_type=Notice&posted_year=2011&_facet_date=comment_end_date"}, {"name": "last_modified", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&document_type=Notice&posted_year=2011&_facet_date=last_modified"}], "next": "2011-11-16T05~3A00~3A00Z,FDA-2011-P-0416-0003", "next_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&document_type=Notice&posted_year=2011&_next=2011-11-16T05~3A00~3A00Z%2CFDA-2011-P-0416-0003&_sort_desc=posted_date", "private": false, "allow_execute_sql": true, "query_ms": 1497.2591690020636, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}